Top compounds associated with response to MC1R


Feature Type Standardized
Nominal ANOVA
mRNA PF-184 CTRPv2 pan-cancer AAC -0.078 0.02
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.03
mRNA cabozantinib CTRPv2 pan-cancer AAC -0.085 0.03
mRNA pluripotin CTRPv2 pan-cancer AAC -0.081 0.03
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.03
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.03
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.03
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.03
mRNA PD318088 CTRPv2 pan-cancer AAC 0.078 0.03
mRNA serdemetan FIMM pan-cancer AAC 0.33 0.03
Download CSV